About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Microbiology research group of the Vall d'Hebron Research Institute (VHIR) focuses on the study of microbiological aspects —in basic, translational and clinical research— that could improve the outcome of patients with infectious diseases.
Our priority research areas are:
We actively collaborate with other microbiology laboratories, health services, national and international centres and organizations, as well as with the different research networks of the Carlos III Health Institute in Spain.
In addition, we carry out an important activity in the surveillance of the genotypic and phenotypic evolution of microorganisms present in the community in terms of their virulence, transmissibility, antigenic escape and antimicrobial resistance, in collaboration with public administrations, both at the national and international level.
IP: Eva Baldrich Rubio Collaborators: Romina Dieli Crimi, Cristina Andrés Vergés Funding agency: Ministerio Ciencia, Innovación y Universidades Funding: 141875 Reference: PID2023-148950OB-C22 Duration: 01/09/2024 - 31/12/2027
IP: Andres Antón Pagarolas Collaborators: Rodrigo Vasquez Mercado, Ignasi Prats Méndez Funding agency: EUROPEAN COMMISSION Funding: 88022.48 Reference: RELECOV-2.0_A.ANTONPAGAROLES_EU4H_2023 Duration: 01/07/2023 - 31/03/2026
IP: Isabel Novoa Garcia Collaborators: Shirley Guzmán Avilés, Joaquim Vives Armengol, Anna Duarri Piqué, Eva Colas Ortega, Oriol Bestard Matamoros, Marta Rosal Fontana, Carmen Espejo Ruiz, Marielle Esteves Coelho, Juan Jose Gonzalez Lopez, Sheyla Pascual Martín, Alejandro Tomasello Weitz Funding agency: Instituto de Salud Carlos III Funding: 137460 Reference: PT23/00040 Duration: 01/01/2024 - 31/12/2026
IP: Susana Otero Romero Collaborators: Imane Boutitah Benyaich, Enrique Rodríguez Zafra, Blanca Borras Bermejo, Anna Falcó Roget, Mar Tintore Subirana, Ana Zabalza de Torres, Daniel Romero Herrero, Jesus Trejo Zahinos Funding agency: Instituto de Salud Carlos III Funding: 115000 Reference: PI23/01654 Duration: 01/01/2024 - 31/12/2026
The technology could help make stool sample screening more comprehensive and facilitate the identification of parasitic findings for subsequent expert review.
The initiative focuses on awareness, prevention, and the normalization of sexual health check-ups among young people.
All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.
